Atossa Therapeutics(MX:ATOS)
MX$39.010.00 (0.00%)
MX:ATOS
Atossa Therapeutics earnings date
MX$39.01
At close:0.00 (0.00%)
Atossa Therapeutics (ATOS) Q3 2026 Earnings Report
0 Followers
MX:ATOS Q3 2026 EPS Results
- Actual EPS
- -MXN 10.42
- Consensus EPS
- -MXN 15.94
- Beat/Miss
- Beat by +MXN 5.52
- One Year Ago EPS
- -MXN 19.53
MX:ATOS Q3 2026 Revenue Results
- Actual Revenue
- MXN 0
- Expected Revenue
- MXN 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/10/2026
- Time
- Before Open
- Conference Call
- Tuesday, November 10, 2026
MX:ATOS Upcoming Earnings
Atossa Therapeutics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ATOS Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | -16.05- | -22.13 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -15.94-10.42 | -19.53 | 46.67% (+9.11) | |
| Aug 07, 2026 | 2026 (Q2) | -19.06-17.67 | -19.53 | 9.52% (+1.86) | |
| May 08, 2026 | 2026 (Q1) | -18.41-20.65 | -13.95 | -48.00% (-6.70) | |
| Mar 25, 2026 | 2025 (Q4) | -21.17-22.13 | -11.16 | -98.33% (-10.97) | |
| Nov 12, 2025 | 2025 (Q3) | -18.13-19.53 | -16.74 | -16.67% (-2.79) | |
| Aug 12, 2025 | 2025 (Q2) | -16.03-19.53 | -13.95 | -40.00% (-5.58) | |
| May 13, 2025 | 2025 (Q1) | -15.81-13.95 | -13.95 | 0.00% (+0.00) | |
| Mar 25, 2025 | 2024 (Q4) | -17.67-11.16 | -16.74 | 33.33% (+5.58) | |
| Nov 12, 2024 | 2024 (Q3) | -16.74-16.74 | -13.95 | -20.00% (-2.79) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
